| Financial Ratios | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Return on Equity | -4.434 | -5.22 | -10.137 |
| Net Profit Margin | -104.54 | - | - |
| Debt to Asset Ratio | 5.242 | 4.428 | 7.7 |
| Cash Ratio | 436.14 | 1,755.791 | 463.566 |
| Quick Ratio | 2,708.247 | 3,636.903 | 2,274.956 |
| Current Ratio | 2,708.247 | 3,636.903 | 2,274.956 |
Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics, Inc. (RAPP)